NewAmsterdam Pharma Company N.V.
NAMS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $40 | $0 | -$40 | -$92 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $15 | $15 | $15 | $9 |
| Change in WC | -$10 | -$24 | $10 | -$8 |
| Other Non-Cash | -$77 | -$29 | -$23 | $53 |
| Operating Cash Flow | -$33 | -$38 | -$36 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$32 | -$184 | -$10 | $0 |
| Inv. Sales/Matur. | $34 | $25 | $13 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$62 |
| Investing Cash Flow | $3 | -$159 | $3 | -$62 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6 | $3 | $0 | $455 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $7 | $2 |
| Financing Cash Flow | $6 | $3 | $7 | $457 |
| Forex Effect | $0 | $9 | $4 | -$8 |
| Net Chg. in Cash | -$24 | -$185 | -$23 | $349 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $564 | $748 | $772 | $423 |
| End Cash | $540 | $564 | $748 | $772 |
| Free Cash Flow | -$33 | -$38 | -$36 | -$37 |